药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Deoxy-2-fluoro-beta-D-cellotrioside
Enrofloxacin
Ferric maltol can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxy-2-fluoro-beta-D-cellotrioside
Flumequine
Ferric maltol can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxy-2-fluoro-beta-D-cellotrioside
Nemonoxacin
Ferric maltol can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxy-2-fluoro-beta-D-cellotrioside
Garenoxacin
Ferric maltol can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxy-2-fluoro-beta-D-cellotrioside
Technetium Tc-99m ciprofloxacin
Ferric maltol can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxy-2-fluoro-beta-D-cellotrioside
Fleroxacin
Ferric maltol can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deoxy-2-fluoro-beta-D-cellotrioside
Deferiprone
The serum concentration of Deferiprone can be decreased when it is combined with Ferric maltol.
Deoxy-2-fluoro-beta-D-cellotrioside
Dimercaprol
Dimercaprol may increase the nephrotoxic activities of Ferric maltol.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Satralizumab
The serum concentration of Prednisolone acetate can be decreased when it is combined with Satralizumab.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Oliceridine
The serum concentration of Oliceridine can be decreased when it is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Abametapir
The serum concentration of Prednisolone acetate can be increased when it is combined with Abametapir.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Cyclopenthiazide
The risk or severity of electrolyte imbalance can be increased when Prednisolone acetate is combined with Cyclopenthiazide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Mebutizide
The risk or severity of electrolyte imbalance can be increased when Prednisolone acetate is combined with Mebutizide.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Lumateperone
The serum concentration of Lumateperone can be decreased when it is combined with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Cenobamate
The serum concentration of Prednisolone acetate can be decreased when it is combined with Cenobamate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Moderna COVID-19 Vaccine
The therapeutic efficacy of Moderna COVID-19 Vaccine can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Modified vaccinia ankara
The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Yersinia pestis 195/p antigen (formaldehyde inactivated)
The therapeutic efficacy of Yersinia pestis 195/p antigen (formaldehyde inactivated) can be decreased when used in combination with Prednisolone acetate.
5-O-phosphono-alpha-D-ribofuranosyl diphosphate
Pertussis vaccine
The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Prednisolone acetate.